Reply to Yasuma <i>et al</i>.-Reference-Cited by-同舟云学术

Reply to Yasuma et al.

Published:2023-12-01 Issue:11 Volume:208 Page:1249-1250
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Norlander Allison E.¹²³^ORCID,Abney Masako¹,Cephus Jacqueline-Yvonne¹,Roe Caroline E.⁴,Irish Jonathan M.⁴,Shelburne Nicholas J.¹,Newcomb Dawn C.¹,Hemnes Anna R.¹^ORCID,Peebles R. Stokes¹⁴⁵

Affiliation:

1. Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, and

2. Department of Cell Biology, Anatomy, and Physiology and

3. Krannert Cardiovascular Research Center, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana

4. Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee;

5. U.S. Department of Veterans Affairs Medical Center, Nashville, Tennessee; and

Funder

Vanderbilt Institute for Clinical and Translational Research

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Biomedical Laboratory Research and Development, VA Office of Research and Development

National Heart, Lung, and Blood Institute

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Link

https://www.atsjournals.org/doi/pdf/10.1164/rccm.202309-1622LE

Reference3 articles.

1. Prostaglandin I₂ Therapy Promotes Regulatory T Cell Generation in Patients with Pulmonary Arterial Hypertension

2. Epoprostenol (Veletri®, Caripul®): A Review of Its Use in Patients with Pulmonary Arterial Hypertension

3. A Comprehensive Review of Treprostinil Pharmacokinetics via Four Routes of Administration